Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT01801163
Title A Phase Ib Study of Stereotactic Body Radiotherapy (SBRT) Plus Sorafenib in Patients With Unresectable Hepatocellular Carcinoma (HCC)
Recruitment Withdrawn
Gender both
Phase Phase I
Variant Requirements No
Sponsors Indiana University
Age Groups: adult
Covered Countries USA

No variant requirements are available.